David Perlin (L) and Charles Rice

'Vac­cines alone are in­suf­fi­cien­t': Mer­ck, Ali­gos work with aca­d­e­m­ic ex­perts to find Covid an­tivi­rals as part of $65M NIH grant

Mer­ck is throw­ing its weight be­hind a new con­sor­tium of aca­d­e­m­ic, non­prof­it and biotech sci­en­tists to dis­cov­er oral an­tivi­rals that can fight Covid-19 — and pan­dem­ic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA